Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
European regulatory conundrum of phage therapy.
Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay JP. Verbeken G, et al. Among authors: vaneechoutte m. Future Microbiol. 2007 Oct;2(5):485-91. doi: 10.2217/17460913.2.5.485. Future Microbiol. 2007. PMID: 17927471
The phage therapy paradigm: prêt-à-porter or sur-mesure?
Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Zizi M, Laire G, Lavigne R, Huys I, Van den Mooter G, Buckling A, Debarbieux L, Pouillot F, Azeredo J, Kutter E, Dublanchet A, Górski A, Adamia R. Pirnay JP, et al. Among authors: vaneechoutte m. Pharm Res. 2011 Apr;28(4):934-7. doi: 10.1007/s11095-010-0313-5. Epub 2010 Nov 10. Pharm Res. 2011. PMID: 21063753 No abstract available.
Quality and safety requirements for sustainable phage therapy products.
Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G. Pirnay JP, et al. Among authors: vaneechoutte m. Pharm Res. 2015 Jul;32(7):2173-9. doi: 10.1007/s11095-014-1617-7. Epub 2015 Jan 14. Pharm Res. 2015. PMID: 25585954 Free PMC article.
A bacteriophage journey at the European Medicines Agency.
Debarbieux L, Pirnay JP, Verbeken G, De Vos D, Merabishvili M, Huys I, Patey O, Schoonjans D, Vaneechoutte M, Zizi M, Rohde C. Debarbieux L, et al. Among authors: vaneechoutte m. FEMS Microbiol Lett. 2016 Jan;363(2):fnv225. doi: 10.1093/femsle/fnv225. Epub 2015 Dec 10. FEMS Microbiol Lett. 2016. PMID: 26656541 Free PMC article.
Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany.
Merabishvili M, De Vos D, Verbeken G, Kropinski AM, Vandenheuvel D, Lavigne R, Wattiau P, Mast J, Ragimbeau C, Mossong J, Scheres J, Chanishvili N, Vaneechoutte M, Pirnay JP. Merabishvili M, et al. Among authors: vaneechoutte m. PLoS One. 2012;7(12):e52709. doi: 10.1371/journal.pone.0052709. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23285164 Free PMC article.
Experimental phage therapy of burn wound infection: difficult first steps.
Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay JP. Rose T, et al. Among authors: vaneechoutte m. Int J Burns Trauma. 2014 Oct 26;4(2):66-73. eCollection 2014. Int J Burns Trauma. 2014. PMID: 25356373 Free PMC article.
280 results